Sunday, December 22, 2024
- Advertisement -spot_img

TAG

Eli Lilly

Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results

Novo Nordisk (NVO) reported its newest GLP-1 product, CagriSema, provides an average of 22.7% weight loss, but that wasn't enough...

In weight loss battle, Novo and Lilly face growing offensive from licenced copies

By Andrew Silver SHANGHAI (Reuters) - As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss...

In weight loss battle, Novo and Lilly face growing offensive from licensed copies

(Corrects typographical error in headline.) By Andrew Silver SHANGHAI (Reuters) -As Novo Nordisk and Eli Lilly expand sales of their...

FDA says knockoff versions of Lilly obesity drug must come off the market

WASHINGTON (AP) — Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity...

Ro partners with Eli Lilly to expand access to Zepbound vials

Eli Lilly (LLY) has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss...

Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some...

Stock market today: Wall Street churns as profit reports come in mixed

NEW YORK (AP) — A mixed set of profit reports from giants like Google’s parent company and Eli Lilly has...

Novo Nordisk Shares Seen Outpacing Lilly’s After Summer Stumble

(Bloomberg) -- Novo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the...

Lilly sues online vendors, medical spa over copycat weight-loss drugs

By Patrick Wingrove(Reuters) - Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide,...

Latest news

- Advertisement -spot_img